The Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market would witness market growth of 7.3% CAGR during the forecast period (2022-2028).
Intravascular ultrasonography (IVUS), coronary computed tomography (CT) angiography, and magnetic resonance imaging (MRI) are new tomographic cardiovascular imaging procedures that can be utilized to assess atherosclerotic particles for the characterization and early staging of coronary artery disease (CAD). Despite the fact that IVUS pictures have a high resolution and can detect very early preclinical CAD, it is an invasive procedure that is only utilized clinically in conjunction with coronary intervention. Noninvasive multiple-slice coronary CT angiography shows potential as a CAD diagnosis technique. In patients without known CAD, new 64-slice cardiac CT technology shows remarkable accuracy for detecting lesions obstructing more than 50% of the lumen, along with sensitivity, specificity, and positive and negative predictive values all better than 90%. Cardiac MRI improves the accuracy of coronary plaque identification and allows for better plaque characterization. The aim would be to identify plaques earlier in the formation of CAD and to describe the plaques most likely to cause a clinical event as tomographic imaging of coronary atheroma improves.
Market players operating in the regional market have major growth prospects in the region due to the significant prevalence of several cardiovascular disorders. According to the National Library of Medicine, in 2019, China was anticipated to have 5.09 million CVD fatalities, with a mortality rate of 364.5 per 100,000 people and an age-standardized mortality rate of 276.0 per 100,000, respectively. Stroke is the main cause of death, with a mortality rate of 171.6 per 100,000 and an age-standardized mortality rate (ASMR) of 130.0 per 100,000, respectively. Ischemic heart disease was the second leading cause, with a death rate of 147.3 per 100,000 and an ASMR of 142.1 per 100,000, respectively. The two leading causes of CVD mortality, ischemic heart disease, and stroke, accounted for almost 87% of all CVD deaths.
The common people's lifestyle in China has changed dramatically as a result of socioeconomic progress. People are increasingly exposed to cardiovascular-related risk factors in China, especially as the population ages and urbanization accelerates, and the prevalence and incidence of cardiovascular disease (CVD) have increased in the last ten years. According to a 2018 report on CVDs in China, the number of patients with cardiovascular disorders in across the country is estimated to be around 290 million, with approximately 13 million suffering from stroke and approximately 11 million suffering from coronary heart disease. CVD is still the leading cause of death in China, accounting for more than 40% of all fatalities in 2016. Among CVDs, stroke was the leading cause of mortality.
The China market dominated the Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $171.4 Million by 2028. The Japan market is poised to grow at a CAGR of 6.6% during (2022 - 2028). Additionally, The India market would display a CAGR of 7.9% during (2022 - 2028).
Based on Modality, the market is segmented into Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Coronary Heart Disease Diagnostic Imaging Devices Market is Projected to reach USD 2.1 Billion by 2028, at a CAGR of 6.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon, Inc. (Canon Medical Systems Corporation), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., and Analogic Corporation (Altaris Capital Partners).
Scope of the Study
Market Segments Covered in the Report:
- Nuclear Medicine
- Computed Tomography
- Ultrasound
- X rays
- Magnetic Resonance Imaging
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Fujifilm Holdings Corporation
- Canon, Inc. (Canon Medical Systems Corporation)
- Mindray Medical International Limited
- Chison Medical Technologies Co., Ltd.
- Analogic Corporation (Altaris Capital Partners)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market, by Modality
1.4.2 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Mar – 2022, Feb) Leading Players
Chapter 4. Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
4.1 Asia Pacific Nuclear Medicine Market by Country
4.2 Asia Pacific Computed Tomography Market by Country
4.3 Asia Pacific Ultrasound Market by Country
4.4 Asia Pacific X rays Market by Country
4.5 Asia Pacific Magnetic Resonance Imaging Market by Country
Chapter 5. Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Country
5.1 China Coronary Heart Disease Diagnostic Imaging Devices Market
5.1.1 China Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.2 Japan Coronary Heart Disease Diagnostic Imaging Devices Market
5.2.1 Japan Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.3 India Coronary Heart Disease Diagnostic Imaging Devices Market
5.3.1 India Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.4 South Korea Coronary Heart Disease Diagnostic Imaging Devices Market
5.4.1 South Korea Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.5 Singapore Coronary Heart Disease Diagnostic Imaging Devices Market
5.5.1 Singapore Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.6 Malaysia Coronary Heart Disease Diagnostic Imaging Devices Market
5.6.1 Malaysia Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.7 Rest of Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market
5.7.1 Rest of Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
Chapter 6. Company Profiles
6.1 General Electric (GE) Co. (GE Healthcare)
6.1.1 Company Overview
6.1.1 Financial Analysis
6.1.2 Segmental and Regional Analysis
6.1.3 Research & Development Expense
6.1.4 Recent Strategies and Developments:
6.1.4.1 Partnerships, Collaborations and Agreements:
6.1.4.2 Approvals and Trials:
6.1.5 SWOT Analysis
6.2 Koninklijke Philips N.V.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Partnerships, Collaborations and Agreements:
6.2.5.2 Acquisitions and Mergers:
6.3 Siemens Healthineers AG (Siemens AG)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent Strategies and Developments:
6.3.5.1 Product Launches and Product Expansions:
6.4 Fujifilm Holdings Corporation
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent Strategies and Developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 Canon, Inc. (Canon Medical Systems Corporation)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Product Launches and Product Expansions:
6.6 Mindray Medical International Limited
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Product Launches and Product Expansions:
6.7 Chison Medical Technologies Co., Ltd.
6.7.1 Company Overview
6.8 Analogic Corporation (Altaris Capital Partners)
6.8.1 Company Overview
TABLE 1 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Coronary Heart Disease Diagnostic Imaging Devices Market
TABLE 4 Product Launches And Product Expansions– Coronary Heart Disease Diagnostic Imaging Devices Market
TABLE 5 Acquisition and Mergers– Coronary Heart Disease Diagnostic Imaging Devices Market
TABLE 6 Approvals and Trials - Coronary Heart Disease Diagnostic Imaging Devices Market
TABLE 7 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Nuclear Medicine Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Nuclear Medicine Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Computed Tomography Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Computed Tomography Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Ultrasound Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Ultrasound Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific X rays Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific X rays Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Magnetic Resonance Imaging Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Magnetic Resonance Imaging Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Country, 2022 - 2028, USD Million
TABLE 21 China Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 22 China Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 23 China Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 24 China Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 25 Japan Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 26 Japan Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 27 Japan Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 28 Japan Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 29 India Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 30 India Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 31 India Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 32 India Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 33 South Korea Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 34 South Korea Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 35 South Korea Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 36 South Korea Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 37 Singapore Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 38 Singapore Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 39 Singapore Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 40 Singapore Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 41 Malaysia Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 42 Malaysia Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 43 Malaysia Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 44 Malaysia Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 45 Rest of Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market, 2018 - 2021, USD Million
TABLE 46 Rest of Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market, 2022 - 2028, USD Million
TABLE 47 Rest of Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2018 - 2021, USD Million
TABLE 48 Rest of Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market by Modality, 2022 - 2028, USD Million
TABLE 49 Key Information – General Electric (GE) Co.
TABLE 50 Key Information – Koninklijke Philips N.V.
TABLE 51 Key Information – Siemens Healthineers AG
TABLE 52 Key Information – Fujifilm Holdings Corporation
TABLE 53 Key Information – Canon, Inc.
TABLE 54 Key Information – Mindray Medical International Limited
TABLE 55 Key Information – CHISON MEDICAL TECHNOLOGIES CO., LTD.
TABLE 56 Key information – Analogic Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, Mar – 2022, Feb) Leading Players
FIG 5 Swot analysis: General electric (GE) Co.
FIG 6 Recent strategies and developments: Koninklijke Philips N.V.
FIG 7 Recent strategies and developments: Canon, Inc.